Focus Partners Wealth
MXCT icon

Focus Partners Wealth’s MaxCyte MXCT Stock Holding History

Focus Partners Wealth’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.3K Buy
+11,818
New +$11K ﹤0.01% 2635

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Focus Partners Wealth's MXCT Position: Q1 2026 in Review

Focus Partners Wealth opened a new position in MaxCyte (MXCT) in Q1 2026: 11,818 shares worth $8.3K. The stake represents ﹤0.01% of the portfolio and ranks #2635 among its holdings.

130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Focus Partners Wealth held 11,818 shares of MaxCyte worth $8.3K as of Q1 2026.
  • MaxCyte was a new Focus Partners Wealth position in Q1 2026.
  • MaxCyte made up ﹤0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #2635 holding.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.